Faderl, S., Ferrajoli, A., Wierda, W., O'Brien, S., Lerner, S., & Keating, M. J. (2010). Alemtuzumab by Continuous Intravenous Infusion Followed by Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence. Cancer.
Citação norma ChicagoFaderl, Stefan, Alessandra Ferrajoli, William Wierda, Susan O'Brien, Susan Lerner, and Michael J. Keating. "Alemtuzumab By Continuous Intravenous Infusion Followed By Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence." Cancer 2010.
Citação norma MLAFaderl, Stefan, et al. "Alemtuzumab By Continuous Intravenous Infusion Followed By Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence." Cancer 2010.